Log in to save to my catalogue

Allergan Applies for Patent on Aryl Urea Derivatives as N-Formyl Peptide Receptor Like-1 (FPRL-1) Re...

Allergan Applies for Patent on Aryl Urea Derivatives as N-Formyl Peptide Receptor Like-1 (FPRL-1) Re...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1836301307

Allergan Applies for Patent on Aryl Urea Derivatives as N-Formyl Peptide Receptor Like-1 (FPRL-1) Receptor Modulators

About this item

Full title

Allergan Applies for Patent on Aryl Urea Derivatives as N-Formyl Peptide Receptor Like-1 (FPRL-1) Receptor Modulators

Publisher

New Delhi: Pedia Content Solutions Pvt. Ltd

Journal title

Global IP News. Pharmaceutical Patent News, 2016

Language

English

Publication information

Publisher

New Delhi: Pedia Content Solutions Pvt. Ltd

Subjects

Subjects and topics

More information

Alternative Titles

Full title

Allergan Applies for Patent on Aryl Urea Derivatives as N-Formyl Peptide Receptor Like-1 (FPRL-1) Receptor Modulators

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_wirefeeds_1836301307

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1836301307

How to access this item